FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

2012 ◽  
Vol 69 (6) ◽  
pp. 1641-1645 ◽  
Author(s):  
Alberto Zaniboni ◽  
Enrico Aitini ◽  
Sandro Barni ◽  
Daris Ferrari ◽  
Stefano Cascinu ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Pancreatic Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Line Chemotherapy

Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Advanced Pancreatic Cancer

Oncology ◽  
2018 ◽  
Vol 96 (1) ◽  
pp. 1-7
Author(s):  
Takuya Ishikawa ◽  
Hiroki Kawashima ◽  
Eizaburo Ohno ◽  
Hiroshi Matsubara ◽  
Yoji Sasaki ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Day Treatment ◽  
Advanced Pancreatic Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Randomized Phase Ii ◽  
Line Chemotherapy

scholarly journals Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial

2007 ◽  
Vol 18 (4) ◽  
pp. 745-751 ◽  
Author(s):  
S. Boeck ◽  
K. Weigang-Köhler ◽  
M. Fuchs ◽  
E. Kettner ◽  
D. Quietzsch ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Pancreatic Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Line Chemotherapy

scholarly journals Biweekly Irinotecan and Cisplatin as Second-line Chemotherapy in Pretreated Patients with Advanced Gastric Cancer: A Multicenter Phase II Study

2005 ◽  
Vol 20 (6) ◽  
pp. 966 ◽  
Author(s):  
Jin Ho Baek ◽  
Jong Gwang Kim ◽  
Sang Kyun Sohn ◽  
Dong Hwan Kim ◽  
Kyu Bo Lee ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Pretreated Patients ◽  
Line Chemotherapy

scholarly journals Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients

2012 ◽  
Vol 3 (6) ◽  
pp. 1314-1318 ◽  
Author(s):  
HYUN JUNG KIM ◽  
JINA YUN ◽  
HAN JO KIM ◽  
KYOUNG HA KIM ◽  
SE HYUNG KIM ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Gemcitabine Refractory ◽  
Line Chemotherapy

S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)

2016 ◽  
Vol 21 (4) ◽  
pp. 705-712 ◽  
Author(s):  
Yuji Miyamoto ◽  
Akihito Tsuji ◽  
Hiroaki Tanioka ◽  
Soichiro Maekawa ◽  
Hirofumi Kawanaka ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Line Chemotherapy

Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine

2010 ◽  
Vol 30 (2) ◽  
pp. 708-713 ◽  
Author(s):  
Takashi Sasaki ◽  
Hiroyuki Isayama ◽  
Yousuke Nakai ◽  
Suguru Mizuno ◽  
Keisuke Yamamoto ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Tract Cancer ◽  
Multicenter Phase ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document